JMF
BIIB icon

Johnson Midwest Financial’s Biogen BIIB Stock Holding History

Johnson Midwest Financial’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$9.25K Hold
36
– – 0.02% 215
2023
Q2 		$10.3K Hold
36
– – 0.01% 204
2023
Q1 		$10K Hold
36
– – 0.01% 201
2022
Q4 		$10K Buy
+36
New +$10.2K 0.04% 196

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Johnson Midwest Financial's BIIB Position: Q3 2023 in Review

Johnson Midwest Financial held its Biogen (BIIB) position steady in Q3 2023 at 36 shares worth $9.25K. The position accounts for 0.02% of the portfolio, ranked #215.

Johnson Midwest Financial first reported a position in BIIB in Q4 2022 and has held it in 4 quarters since. The position peaked at $10.3K in Q2 2023. 965 funds tracked by Wall St. Rank hold BIIB as of Q3 2023.

  • Johnson Midwest Financial held 36 shares of Biogen worth $9.25K as of Q3 2023.
  • Johnson Midwest Financial left its Biogen share count unchanged in Q3 2023.
  • Biogen made up 0.02% of Johnson Midwest Financial's portfolio in Q3 2023, its #215 holding.
  • Johnson Midwest Financial first reported a position in Biogen in Q4 2022 and has held it in 4 quarters since.
  • Johnson Midwest Financial's Biogen position peaked at $10.3K in Q2 2023.
  • 965 funds tracked by Wall St. Rank held Biogen as of Q3 2023.

Based on Johnson Midwest Financial's 13F filing for Q3 2023, filed 7 Nov 2023.